Regenerative Medical Technology Group Inc.
Cash Flow Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-7.8M | $-5.6M | $-9.8M | $-5.5M | $-12.9M | $-5.9M | $-2.5M | $-2.1M |
| Depreciation & Amortization | $281.1K | $220.6K | $310.1K | $152.7K | $40.9K | $800 | $800 | $200 |
| Depreciation | $183.5K | $123.0K | $212.6K | $55.2K | $40.1K | $800 | $800 | $200 |
| Amortization | $97.5K | $97.5K | $97.5K | — | — | — | — | — |
| Stock-Based Compensation | — | — | — | — | — | — | $1.2M | — |
| Net Cash from Operating Activities | $-706.5K | $850.7K | $-419.2K | $-1.1M | $-9.9M | $-322.7K | $-362.3K | $-244.6K |
| Investing Activities | ||||||||
| Capital Expenditures | $602.6K | $215.4K | $385.6K | $198.4K | — | $100.0K | $100.0K | $4.0K |
| Business Acquisitions | — | — | — | — | — | $175.0K | — | — |
| Net Cash from Investing Activities | $-602.6K | $-215.4K | $-385.6K | $-198.4K | $666.5K | $-175.0K | — | $-4.0K |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $1.1M | — | $-309.9K | $-20.8K | $12.1M | $516.9K | $354.9K | $271.7K |
| Net Change in Cash | — | — | — | $-1.3M | $2.9M | $19.2K | $-7.5K | $23.1K |
| Free Cash Flow | $-1.3M | $635.3K | $-804.8K | $-1.3M | — | $-422.7K | $-462.3K | $-248.6K |